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ABSTRACT 
Vein grafting is complicated by high rates of stenosis due to the development of vascular 
inflammation, intimal hyperplasia and accelerated atherosclerosis. In contrast, arterial 
grafts are relatively resistant to these processes. Vascular inflammation is regulated by 
MAP kinases (including JNK and p38) and NF-κB signaling pathways which trigger 
endothelial expression of adhesion molecules (e.g. E-selectin, VCAM-1) and chemokines 
(e.g. IL-8, MCP-1).  
 
Blood flow over lumenal surfaces generates haemodynamic forces. Changes in flow have 
profound effects on the physiology of endothelial cells. This may influence disease 
processes that are associated with perturbations in flow, e.g. intimal thickening. Here we 
examined the effects of acute arterial shear stress (12 dynes/cm2) on pro-inflammatory 
activation of porcine aortic endothelial cells (PAEC) or porcine jugular vein endothelial 
cells (PJVEC).  We also examined whether induction of anti-inflammatory transcripts 
accompanied the induction of pro-inflammatory mRNA. 
 
PAEC and PJVEC monolayers were plated onto gelatin-coated glass slides and cultured 
for 48h before experimentation. Cultures were then placed in a vacuum-held, parallel-
plate flow chamber (Figure 2.2). Fluid was circulated through the chamber via a flow 
loop that held a constant flow rate, so that the shear stress imposed on the endothelial 
cells layer was 12 dynes/cm2 (equivalent to arterial flow) (Figure 2.1). Cells were 
cultured in static conditions or exposed to acute shear or TNFα (10ng/ml) for two and 
four hours or thirty and ninety minutes to look at gene expresssion and MAP kinase 
activation 
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respectively. Transcript levels were quantified using reverse transcription, real-time 
quantitative PCR. The amount of each target gene was normalized by measuring 
cyclophilin mRNA levels. The effect of shear stress on pro-inflammatory MAP kinases 
and NF-κB was assessed by western blotting for a phosphorylated form of JNK and p38, 
and nuclear translocation of p65. 
 
We observed that arterial shear stress induced high levels of IL-8, MCP-1 and E-selectin 
transcripts in PJVEC whereas PAEC were relatively resistant to the pro-inflammatory 
effects of shear stress (Figure 3.3 and Figure 3.4). To investigate the potential mechanism 
underlying the differential responses of PJVEC and PAEC we examined the effects of 
shear stress on the activation of NF-κB, JNK and p38. We observed that shear stress 
induced prolonged activation of JNK and p38 in PJVEC but only transient activation in 
PAEC. In contrast, the kinetics of NF-κB activation in response to shear were similar in 
both cell types (Figure 3.6 and Figure 3.7). Thus prolonged activity of MAP kinases may 
explain the hypersensitivity of PJVEC to shear stress mediated activation. Finally, we 
observed that anti-inflammatory transcripts (MKP-1 and XIAP) are induced by shear 
stress in PAEC but not in PJVEC (Figure 3.11), thus PAEC may resist pro-inflammatory 
activation by shear stress through inhibition of MAPK by molecules such as MKP-1 and 
XIAP. We suggest that the hypersensitivity of venous EC to the pro-inflammatory effects 
of shear stress may partly explain the susceptibility of vein grafts to inflammation and 
accelerated atherosclerosis. 
 
 
  
 
7 
ABBREVIATIONS 
 
AP-1 activating protein-1 
ATF2 activating transcription factor 2 
BMK1 big MAP kinase 1  
BSA bovine serum albumin 
cDNA complementary DNA 
COX-2 cyclo-oxygenase-2 
DTT dithiothreitol 
EC endothelial cell 
ECGF Endothelial cell growth factor 
ERK extracellular signal-regulated protein kinases 
HBSS Hanks' balanced salt solution 
HRP horseradish peroxidase 
HUVEC human umbilical vein endothelial cell 
ICAM-1 intercellular adhesion molecule-1 
IH intimal hyperplasia 
IHC immunohistochemistry 
IL-1 interleukin-1 
IL-12 interleukin-12 
IL-6 interleukin-6 
IL-8 interleukin-8 
IP-10 interferon-γ inducible protein-10 
JDP jun dimerization protein 
JNK c-Jun NH2-terminal kinase 
Keap-1 kelch-like ECH-associated protein 1 
LSM laser scanning microscopy 
MAPK or MAP kinase mitogen-activated protein kinase 
MAPKK or MAPK kinsase MAP kinase kinase 
MAPKKK or MAP3K MAP kinase kinase kinase 
  
 
8 
MCP-1 monocyte chemoattractant protein-1 
MKP-1 MAP-kinase phosphatase-1 
NF-κB  nuclear factor-κB 
Nrf2 NF-E2-related factor-2 
PAEC porcine aortic endothelial cell 
PBS phosphate buffered saline  
PCR polymerase chain-reaction 
PJVEC porcine jugular vein endothelial cell 
Pro proline 
RHD Rel homology domain  
RT-PCR reverse transcription polymerase chain-reaction 
SAPK stress activated protein kinase 
SDS sodium dodecyl sulphate 
SMC smooth muscle cell 
TAK1 transforming growth factor-β activated kinase 1  
Thr threonine 
TLR toll-like receptor 
TNFα tumor necrosis factor α 
TRAF tumor-necrosis-factor-receptor-associated-factor 
Tyr tyrosine 
VCAM-1 vascular cell adhesion molecule-1 
XIAP X-chromosome-linked inhibitor of apoptosis protein 
   
 
 
9 
1. INTRODUCTION 
1.1. Inflammation 
Inflammation is a localised physiological response to injury or infection characterised by 
redness, swelling, warmth, pain and altered function. Its purpose is to neutralise 
damaging agents and repair damaged tissues. Acute inflammation occurs within seconds, 
minutes or hours whereas chronic inflammation is characterised by a prolonged time 
course, sometimes provoked by resistance of the harmful agent. 
 
Acute inflammation is a complex prosess in which a variety of events contribute, starting 
with vascular dilatation, which enhances blood flow to tissues. This is followed by 
endothelial activation which is characterised by expression of adhesion molecules such as 
vascular cell adhesion molecule-1 (VCAM-1), E-selectin and intercellular adhesion 
molecule-1 (ICAM-1) which regulate binding of immune cells. Further, the activation of 
integrins on leukocyte surfaces allows their adherence to activated endothelium via 
interactions between integrins and endothelial adhesion molecules. This step facilitates 
subsequent transmigration of leukocytes into underlying tissues in a process known as the 
“adhesion cascade”. 
 
Chronic inflammation is a continuum of acute inflammation that occurs when the 
causative stimulus of the inflammatory response is maintained or because of aberrations 
in the immune system. It causes concomitant tissue destruction and repair and is involved 
in the pathogenesis of many diseases, such as rheumatoid arthritis and atherosclerosis.  
INTRODUCTION 
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1.1.1. Biology of the blood vessel wall 
The blood vessel wall consists of three layers: the intima, the media and the adventitia 
(Figure 1.1). The innermost layer is the intima, which is comprised of a layer of 
endothelial cells (EC) lying on a thin layer known as the internal elastic lamina. The 
medial layer consists of smooth muscle cells (SMC) and extra cellular matrix supported 
by the external elastic lamina. This medial layer is generally thicker in arteries than in 
veins. Outermost is the adventitial layer which contains fibroblasts, extra cellular matrix 
and nerves (Mitra et al., 2006). 
 
 
Figure 1.1 Anatomy of an artery (Internet reference 1)  
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1.1.2. Adhesion of leukocytes to activated endothelial cells 
Endothelial cells line the interior surface of the blood vessels (Figure 1.1). The 
endothelium is more than a static barrier between the circulating blood and the rest of the 
vessel wall, it is a dynamic structure that adapts rapidly to changes in the surrounding 
environment. The endothelium plays a key role in regulating important physiological 
functions like blood pressure, blood clotting and inflammation.  
 
The recruitment of monocytes in blood to sites of inflammation is the first step in their 
passage into inflamed tissues. This process is mediated by the adhesion cascade, which is 
comprised of a series of adhesion and activation steps (Springer, 1995) (Figure 1.2). Thus, 
selectins are largely responsible for initial capture of leukocytes from the blood stream, 
and also mediate subsequent rolling on the endothelial surface. Activation of rolling 
leukocytes by chemoattractants leads to increased avidity and/or affinity of leukocyte 
integrins and the arrest of leukocytes on the endothelial surface, followed by their 
transendothelial migration into the extravascular space. The capacity of EC to support 
interactions with leukocytes is stimulated in inflammation by the induction of numerous 
proteins involved in the adhesion cascade, including adhesion molecules (e.g. E-selectin, 
VCAM-1, ICAM-1), cytokines (e.g. tumor necrosis factor α (TNFα), interleukin-1 (IL-1)) 
and chemokines (e.g. monocyte chemoattractant protein-1 (MCP-1), interleukin-8 (IL-8)).  
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Figure 1.2 Adhesion and arrest of cicrulating leukocytes  Adapted from (Springer, 1995) 
 
 
1.2. Pro-inflammatory mediators 
1.2.1. Chemokines 
The chemokines MCP-1 and IL-8 are important mediators of inflammation. MCP-1 
attracts monocytes such as eosinphils and basophils and T-lymphocytes, whereas IL-8 is 
known to attract neutrophiles and basophiles to the site of inflammation (Springer, 1995). 
IP-10 (interferon-γ inducible protein 10) is known to have monocyte attractant properties 
as well as to contribute to leukocyte adhesion to endothelial cells. 
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1.2.2. Selectins 
The selectin family of proteins consist of E-selectin, P-selectin and L-selectin. 
They are membrane bound adhesion molecules which upon cell activation will be 
expressed on the cell surface, and in turn bind to circulating leukocytes, thus contributing 
to vascular inflammation. E-selectin is solely expressed on endothelial surfaces and it is 
transcriptionally silent in quiescent EC. Upon endothelial activation by cytokines such as 
TNFα and IL-1 (Wadgaonkar et al., 2004) or acute flow (Burns and DePaola, 2005), the 
transcription of E-selectin is induced. P-selectin however, is expressed on both blood 
platelets and in endothelial cells, where they are preformed and stored in Weibel-Palade 
bodies. Upon EC activation, P-selectin is rapidly mobilized to the plasma membrane to 
bind monocytes and neutrophils (Springer, 1995). L-selectin is expressed on all 
circulating leukocytes, except for a subpopulation of lymphocytes (Springer, 1995). 
 
1.2.3. Other adhesion molecules 
VCAM-1 and ICAM-1 are adhesion molecules that play essential roles in the capture and 
arrest of circulating leukocytes to vascular endothelium. VCAM-1 and ICAM-1 has been 
shown to be expressed in response to cytokine stimulation and acute flow (Burns and 
DePaola, 2005; Morigi et al., 1995a; Morigi et al. 1995b; Nagel et al., 1994). 
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PRO-INFLAMMATORY SIGNALLING PATHWAYS AND THEIR REGULATION 
 
1.3. Mitogen activated protein kinases (MAPK) 
MAP kinases are among the most ancient signal transduction pathways and are used to 
regulate a vide range of physiological processes in the immune response (Dong et al., 
2002). The MAPK-family consists of four MAP kinases; the extracellular signal-
regulated protein kinases (ERK), the p38 MAP kinases, the c-Jun NH2-terminal kinases 
(JNK) and the big MAP kinase 1 (BMK1, sometimes known as ERK5). (Zarubin and 
Han, 2005). The MAPK’s are all activated by dual phosphorylation of Thr-X-Tyr 
residues, where X is a distinct amino acid for each MAPK member. The activaton of the 
MAPKs are mediated through MAPK kinases (MKKs), and in turn, the MKKs are 
phosphorylated by the serine/threonine kinases termed MKKKs (M3Ks) (Kumar et al., 
2003). Thus the MAPKs are activated by a kinase signaling cascade (Figure 1.3).  
 
 
Figure 1.3 Stress-Activated MAPK Signaling Modules  The JNK and p38 MAPK are activated by dual 
phosphorylation on Thr and Tyr caused by members of the MAPKK group of protein kinases. The 
MAPKK are activated, in turn, by phosphorylation mediated by a group of MAPKKK. Stress-activated 
MAPK signaling modules can be created through the sequential actions of a MAPKKK, a MAPKK, and a 
MAPK (Davis, 2000). 
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It is known that the ERK 1/2 and BMK1 are activated by mitogenic and proliferative 
stimuli (Dong et al., 2002 and Hoefen and Berk, 2002), wheras the JNKs and p38 
MAPKs are activated by environmental stress, like heat, osmotic shock and UV light, as 
well as inflammatory cyokines. It is thought that the pro-inflammatory or cytoprotective 
response in EC is regulated in part by the balance between the pro- or anti-inflammatory 
MAPK activities (Hoefen and Berk, 2002) (Figure 1.4). 
 
 
 
Figure 1.4 MAPK involvement in endothelial activation and inflammation The pro-infllammatory 
MAPKs; p38 and JNK, are activated in response to environmental stress and promotes an inflammation 
(Hoefen and Berk, 2002) 
 
 
Activated forms of p38 and JNK are known to further facilitate transcription of pro-
inflammatory cytokines (e.g. IL-8, IL-12, MCP-1, and TNFα) and adhesion molecules 
(e.g. E-selectin and VCAM-1) (Dong et al., 2002). ERK1/2 however, may play a 
predominantly cytoprotective role in EC by suppressing the activity of JNK or p38 
INTRODUCTION 
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(Hoefen and Berk, 2002) or by upregulating eNOS (Nakata et al., 2005). ERK and 
BMK1 are as previously mentioned primarily involved in growth and cytoprotective 
functions (Hoefen and Berk, 2002) and are not considered further in this study. 
 
1.3.1. p38 
p38 is a member of the MAP kinase proteins and is known to be an important regulator of 
many diverse processes: inflammation, cell growth and differentiation, and cell survival. 
In this project I will focus on the pro-inflammatory properties of p38. 
 
p38 has a molecular weight of 38 kDa and there are five isoforms known: p38α, p38β, 
p38β2, p38δ, p38γ, where p38α (often denoted as just p38) is best characterized and 
suggested as the most important isoform involved in inflammatory response (Kumar et 
al., 2003). p38α and p38β are ubiquitously expressed, while the other isoforms are 
differentially expressed depending on tissue type (Zarubin and Han, 2005).  
 
Under quiescent conditions p38 resides in the cytoplasm in an unactive state. However, in 
response to cytokines (e.g. TNFα or IL-1), growth factors or stress, p38 is known to be 
dually phosphorylated on Thr180 and Tyr182 (Herlaar and Brown, 1999).  MKK3 and 
MKK6 are the two main MKKs that are known to activate p38, although MKK4, an 
upstream kinase of JNK, has been suggested to aid in the p38 activation (Zarubin and 
Han, 2005). 
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Further upstream, the MKKs are activated by a diverse range of MKKKs (MAP3Ks), 
including TAK1, ASK1/MAP3K5, DLK/MUK/ZPK and MEKK4 (Zarubin and Han, 
2005). The MAP3Ks are in turn activated by Rho-family proteins, such as Rac and cdc42 
(Zarubin and Han, 2005). Many of the p38 MAP3Ks are also involved in activation of the 
JNK pathway, and this is a possible reason for why these two pathways often are co-
activated. 
 
Activated p38 triggers pro-inflammatory signalling by activating transcription factors, 
and this pathway is strongly linked to diseases like Alzheimers’, rhematoid arthritis, 
inflammatory bowel disease, and possibly atherosclerosis. Through activation of 
transcription factors such as ATF1/2/6 and Elk-1, p38 plays an important role in the 
production of pro-inflammatory cytokines (e.g. IL-1, IL-6 and TNFα) and 
cyclooygenase-2 (COX-2) (Guan et al., 1998), as well as adhesion molecules such as 
VCAM-1 (Pietersma, 1997). 
 
1.3.2. JNK 
JNK (sometimes denoted as Stress activated protein kinase, SAPK) is a member of the 
MAPK family and is involved in pro-inflammatory signalling transduction in response to 
various stimuli such as cytokines (e.g. TNFα and IL-1) and mechano-sensory stimulation 
by shear. There are 3 known members of the JNK family: JNK1 (46 kDa), JNK2 (54 
kDa) and JNK3.  
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Cytokines or extracellular stress (e.g. shear stress from fluid flow) will through TLRs or 
mechanosensory receptors activate Rac or cdc42 which in turn leads to activation of 
MAP3Ks, including transforming growth factor-β activated kinase 1 (TAK1). The 
MAP3Ks will futher phosphorylate MKK4 and/or MKK7 which is followed by dual 
phosphorylation of JNK on its Thr-Pro-Tyr residues. This in turn leads to 
phosphorylation and nuclear translocation of c-Jun, JunB, JunD and ATF2 (Ip and Davis, 
1998) which are members of the activator protein 1 (AP-1) superfamily of transcription 
factors. AP-1 family members form dimers and are known to transcribe pro-inflammatory 
genes such as MCP-1. 
 
Recent studies has revealed that an upstream MAP3K, TAK1, is crucial for JNK 
activation in response to cytokines (e.g. IL-1 and TNF-α) and for JNK activation through 
TLRs (Weston and Davis, 2007) (Figure 1.5). It is further thought that JNK activation in 
response to cytokines is mediated thorough MKK7, while MKK4 mediates activation in 
response to enviromental stress (Davis, 2000) 
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Figure 1.5 The role of TAK1 in JNK signalling TAK1 plays a central role in JNK activation 
mediated by inflammatory cytokines and Toll-like receptors (adapted from Weston and Davis, 2007). 
 
 
1.4.  Nuclear factor- κB (NF-κB) 
NF-κB is an important transcription factor in pro-inflammatory-, cytoprotective- and anti-
apoptotic signalling transduction. It is previously shown that endothelial cells upon 
activation express high levels of IL-8, MCP-1 and E-selectin among other 
proinflammatory proteins, and it is commonly thought that this inflammatory response is 
mainly due to NF-κB (p65) and MAPK signalling. 
 
p65 (RelA) is a subunit in the NF-κB family of proteins along with RelB, c-Rel, NF-κB1 
(p50 and its precursor 105) and NF-κB2 (p52 and its precursor p100). NF-κB is a 
transcription factor that forms either homodimers or heterodimers. NF-κB proteins share 
a conserved Rel homology domain (RHD) in their N-terminal region that is involved in 
INTRODUCTION 
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DNA binding and dimerization and interaction with the members of the inhibitor of κB 
(IκB) family. The p65-p50 heterodimer was defined as the classical NF-κB binding form, 
but this is only one of the multiple species that can bind to κB sites on the DNA strands. 
The most prevalent activated form of NF-κB is a heterodimer consisting of a p50 subunit 
and p65. The diverse regulation of NF-κB-dependent promoters is due to the ability of 
different dimers to bind to distinct κB sites in a cell-type- and stimulus-dependent 
manner.  
 
Under quiescent conditions the NF-κB dimer is sequestered in the cytoplasm by IκB. The 
IκB family is composed of IκBα, IκBβ, IκBγ, IκBε, Bcl-3 and the NF-κB precursors 
p100 and  p105 and is characterised by the presence of ankyrin repeats (Whiteside and 
Israel, 1997). IκBs exert their inhibitory effects via the ankyrin region which binds to the 
RHD domains of NF-κB dimers. This interaction blocks NF-κB nuclear translocation by 
masking its nuclear localisation signal (Karin, 1999). However, upon activation by 
cytokines or stress (e.g. oxidative stress or acute shear stress) IκB is degraded by 
proteosomes, and NF-κB translocates to the nucleus and commence transcription of pro-
inflammatory genes (Figure 1.6).  
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Figure 1.6 Activation of NF-κB IκB is phosphorylated, which leads to its ubiquitination. This signals a 
proteasome to degrade IκB and allows NF-κB to translocate into the nucleus and bind to κB (Internet 
reference 2) 
 
1.5. Resolution of inflammation 
The inactivation of inflammation is an active process that operates at different levels. It 
involves depletion of inflammatory cells by apoptosis and phagocytosis. It also involves 
inactivation of NF-κB and AP-1 transcription factors thus suppressing expression of pro-
inflammatory genes.  
1.5.1. Downregulation of MAPK activity 
MAP kinase activation is often transient, and the level of total MAP kinase does not 
change throughout the course of the activation – inactivation, thus dephosphorylation is 
the main mechanism of inactivation (Zarubin and Han, 2005). An important group of 
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dual-specificity phosphatases are known as the MAP kinase phosphatases (MKPs), where 
MKP-1 is the most extensively studied. 
 
There is a positive feedback loop in the regulation of p38 and JNK in that they both get 
activated in response to cytokines (e.g. IL-1 and TNFα) and upon activation they lead to 
increased expression of these same cytokines. There is however, a downregulation 
mechanism of MAPK through transcription of MKP-1 (Wadgaonkar et al., 2004), a 
molecule that dephosphorylates activated MAP-kinases and thereby blocks downstream 
MAP-kinase signalling transduction (Wadgaonkar et al., 2004). Although downregulation 
of JNK is poorly understood, recent studies on knockout mice have showed that knocking 
down MKP-1 and MKP5 increased JNK activity (Weston and Davis, 2007). Thus it is 
suggested that the MAPK phosphatases are important in resolving inflammatory 
responses by inhibiting signal transduction caused by p38 and JNK MAP-kinases. 
 
XIAP is a protein that has been proposed as an important mediator in the anti-apoptotic 
signalling route in the NF-κB pathway by blocking NF-κB crosstalk with JNK and 
thereby inhibiting pro-inflammatory signal transduction (Nakano, 2004). The 
upregulation of XIAP may thus be an important gene to investigate further. 
 
Nrf2 is a transcription factor that resides in the cytoplasm bound to Keap-1 under 
quiescent conditions. Keap-1 is a cytoplasmic protein that is associated with the 
cytoskeleton. It is known to bind to Nrf2 and thus sequester this transcription factor in the 
cytoplasm (Mann et al., 2007). Upon activation, Nrf2 dissociates from Keap-1 and 
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translocates into the nucleus where it binds to antioxidant response element (ARE) 
promoters and thereby induce transcription of antioxidant genes (Mann et al., 2007). 
Importantly, Nrf2 is known to suppress the activity of p38 and is thus potentially 
implicated in the resolution of inflammation. 
 
1.5.2. Suppression of NF-κB 
Suppression of NF-κB is controlled by multiple negative feedback mechanisms involving 
NF-κB-dependent induction of multiple regulatory proteins (IκB and A20). 
Export of NF-κB from the nucleus is known to terminate transcription of NF-κB 
dependent genes (Arenzana-Seisdedos et al, 1997 and Rodriguez et al., 1999). This step 
is carried out by IκBα that is newly synthesised in response to NF-κB activation. This 
IκBα binds to nuclear NF-κB and shuttles it back to the cytoplasm where it is then 
retained in an inactive form (Huang et al., 2000).     
 
The A20 gene is activated by NF-κB (Krikos et al., 1992). In addition, A20 suppresses 
activation of NF-κB and induction of pro-inflammatory transcripts in response to TNFα 
or IL-1 (Jaattela et al., 1996 and Krikos et al., 1992). The mechanism is not fully 
understood, but it is thought that A20 acts through binding to tumor-necrosis-factor-
receptor-associated-factor (TRAF) molecules which are necessary for pro-inflammatory 
signalling (Evans P.C., 2001). Elevated levels of A20 will therefore block the pro-
inflammatory transciption through the NF-κB signalling pathway in response to stimuli 
such as cytokines or flow. 
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Cezanne is a relatively recently discovered molecule in the A20-family. It is a zinc finger 
protein that is shown to play a part in NF-κB downregulation (Evans P.C., 2001). Thus it 
is thought to have a cytoprotective role in endothelial cells. 
 
1.6. Inflammatory processes in atherosclerosis 
Atherosclerosis  is regarded as a chronic inflammatory disease (Ross, 1999) and intimal 
hyperplasia  occurs at sites of inflammation. As a graft is inserted into the bloodstream 
and reperfused, altered hemodynamics will activate the endothelial layer of the graft, and 
inflammation will commence. Leukocytes and platelets adhere to the inflammation site 
and macrophages transmigrate into the subendothelial layers. These macrophages 
accumulate oxidised LDL and differentiate into foam cells. The foam cells produce 
growth factors that cause the smooth muscle cells (SMC) in the medial layer to 
proliferate. The SMC start to migrate to the intima and continues their proliferation. The 
intima is further thickened and underlying fibroblasts start to migrate to the damaged 
area, differentiating into myofibroblasts (Mitra et al., 2006). At these sites of intimal 
hyperplasia, atherosclerosis is prone to occur due to altered flow patterns and loss of 
athero-protective response from prolonged high laminar shear (Sheikh et al., 2002; 
Sheikh et al., 2005; Yamawaki et al., 2003). 
1.6.1. Coronary artery bypass grafting 
When atherosclerotic lesions form in the coronary arteries, the lesion might eventually 
lead to ischemic heart disease, followed by myocardial infaction. In some cases, patients 
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are treated by re-opening the occluded vessel by balloon angioplasty or stenting. 
However, in many cases the patient needs surgical revascularisation (or coronary artery 
bypass grafting), in which an endogenous artery or vein is transposed into the blocked 
coronary artery “below” the point of occlusion, and thereby supplies the mycardium with 
freshly oxygenised blood (Figure 1.7). Indications for coronary artery bypass grafting (or 
simply bypass surgery) are most often angina that persists or progress despite medical 
therapy and prolongation of life in high-risk patients (Canver, 1995).  
 
The conduit to be used during coronary artery bypass grafting depends, in part, on the 
anatomical site of the occlusion and the clinical condition of the patient. The internal 
mammary artery (or the internal thoracic artery) is, among cardiothoracic surgeons, the 
preferred conduit (Gardner, 2007). However, in patients with multiple occlutions or when 
the internal mammary artery is unsuited as a conduit other options has to be considered, 
and the greater saphenous veins is often the conduit of choice. 
  
Human saphenous vein grafts are the most used conduits in cardiac surgery (Canver, 
1995), however their use is usually complicated by high rates of late stenosis and 
eventual luminal occlusion due to the development of intimal hyperplasia and accelerated 
atherosclerosis. Outside of early graft thrombosis which is frequently technically related, 
vein grafts can develop accelerated intimal hyperplasia as early as one month following 
surgery (Mitra et al., 2006). Accelerated intimal hyperplasia can significantly reduce 
lumen area, and increases the propensity of veins to develop accelerated atherosclerosis 
causing failure of up to 40% of vein grafts within 10 years of surgery (Motwani and 
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Topol, 1998), leading in turn to recurrence of clinical symptoms such as angina, and 
increasing the risk of re-infarction. It is therefore interesting to note that, the internal 
mammary artery grafts, when compared to venous grafts, are almost resistant to 
restenosis (Mitra et al., 2006).  
 
 
Figure 1.7 Bypass surgery using either a saphenous vein graft or a internal mammary artery 
Coronary artery bypass surgery consists of attaching an artery or part of a vein to a coronary artery, so that 
the blood has an alternate route to the coronary arteries. As a result, the narrowed or blocked area is 
bypassed (Internet reference 3) 
 
1.6.2. Monocyte-macrophages regulate accelerated atherosclerosis in vein grafts 
Vein grafts are particularly susceptible to accelerated atherosclerosis which is 
characterised by the influx of inflammatory cells and proliferation of smooth muscle 
cells, processes that lead to thickening of the intima.  
Several lines of evidence suggest that inflammatory cells contribute to the pathogenesis of 
accelerated atherosclerosis in vein grafts: Firstly, macrophages have been detected at early 
stages following vein to artery transposition in humans (Amano et al., 1991) and rats 
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(Hoch et al. 1994) and macrophages are more abundant in vein grafts than in native 
atherosclerotic lesions (Ratliff and Myles, 1989). Secondly, the process of vein grafting 
induces expression of adhesion molecules (Kwei et al., 2004) and chemokines (Stark et 
al., 1997) in EC within 6-24 hours following surgery, thus facilitating early inflammatory 
responses. Finally, vein graft disease is reduced by depletion of macrophages (Hoch et al., 
1999) or by genetic deletion of  known pro-inflammatory genes such as ICAM-1 (Zou et 
al., 2000) or the p55TNF receptor (Zhang et al., 2004), which suggests that inflammatory 
cells contribute to pathogenesis. Thus prevention of early inflammation may protect from 
intimal hyperplasia and secondary atherosclerosis in vein grafts.  
 
 
1.6.3. Inflammation-related signalling mechanisms in vein graft endothelium 
Pro-inflammatory activation of EC requires the activation of MAPK and NF-κB 
signalling pathways (Ghosh et al., 1998 and Dong et al., 2002 ) which makes them 
potential targets for anti-inflammatory therapies.  
 
Pro-inflammatory signalling generates active, phosphorylated forms of JNK and p38 
(Dong et al., 2002) which activate transcription factors belonging to the activator protein-
1 (AP-1) family (including c-Jun, ATF2 and c-Fos) and other cellular proteins through 
ATP-dependent phosphorylation (Dong et al., 2002). Studies using cultured cells revealed 
that the JNK/p38-AP1 signalling pathway is essential for the induction of VCAM-1 
(Ahmad et al., 1998), E-selectin (Read and Whitley, 1997 and Min and Prober, 1997) and 
IL-8 (Natarajan et al., 2001 and Parhar et al., 2003) proteins in activated EC. JNK and 
p38 are activated rapidly by phosphorylation in vein bypass grafts (Saunders et al., 2004 
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and Cornelissen et al., 2004). However, the exact role of MAP kinases in relation to vein 
graft disease and their mode of regulation remain largely unknown. 
 
1.7. Effects of shear stress on vascular inflammation: potential 
relevance in vein grafting 
Blood flow exerts shear stress (mechanical drag) on vascular endothelium, which varies in 
time, magnitude and direction according to vascular pulsatility and anatomy. Artery walls 
are exposed to much higher shear stresses (12-20 dynes/cm2) compared to vein walls (<5 
dynes/cm2). It is widely believed that shear stress regulates the susceptibility of the 
arterial tree to atherosclerosis by altering EC physiology. Prolonged high laminar shear 
suppresses atherosclerosis in regions of the arterial tree with uniform geometry by 
exerting several 'protective' effects on EC, including inhibition of the cell cycle (Lin et al., 
2000), suppression of thrombosis (Grabowski et al., 2001), promotion of viability 
(Dimmeler et al., 1996) and suppression of inflammatory activation (Sheikh et al., 2003; 
Sheikh et al., 2005; Yamawaki et al., 2003).  In contrast, atherosclerosis occurs 
predominantly at arches and branches of the arterial tree that are exposed to low shear or 
complex flow patterns (Dai et al., 2004 and Cunningham and Gotlieb, 2005).    
 
Shear stress regulates vascular physiology by altering EC through mechanosensory 
receptors which converts mechanical forces into biochemical signals (Grabowski et al., 
2001; Lan et al, 1994; Lin et al., 2000; Sheikh et al., 2003; Yamawaki et al., 2003). 
Exposure of cultured EC to high laminar shear has profound effects on pro-inflammatory 
signalling. Acute induction of arterial shear stress (5m - 4h) is known to activate JNK (Li 
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et al., 1996 and Miao et al., 2002) and NF-κB (Bhullar et al., 1998; Davis ME et al., 
2004; Hay et al., 2003; Lan et al., 1994) and trigger the expression of ICAM-1 (Burns and 
DePaola, 2005; Morigi et al., 1994a; Nagel et al., 1994), VCAM-1 (Gonzales and Wick, 
1996) and E-selectin (Burns and DePaola, 2005) in EC, thus facilitating leukocyte 
adhesion (Burns and DePaola, 2005; Gonzales and Wick, 1995; Morigi et al., 1995; Nagel 
et al., 1995). Exposure of venous endothelial cells to arterial flow following transposition 
to the arterial circulation could thereby lead to activation of pro-inflammatory signaling 
pathways and expression of adhesion proteins, chemokines and cytokines. 
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1.8. Hypothesis and aims of present study 
 
We hypothesise that the relative susceptibility of vein grafts to inflammation compared to 
artery grafts may be a consequence of different responses of venous EC and arterial EC to 
shear stress induced by arterial blood flow.  
 
We now wish to know:  
(i) whether elevating shear from venous (<5 dynes/cm2) to arterial (12-20 
dynes/cm2) levels (or from static to arterial shear) activates cultured porcine 
jugular vein EC (PJVEC)  
(ii) whether the induction of pro-inflammatory mRNA is accompanied by 
indiction of cytoprotective transcripts (MKP-1, A20, Cezanne, XIAP, Keap-1, 
Nrf2)  
(iii) whether PJVEC respond to flow in the same way as aortic EC  
(iv) whether inactivation of MAP kinases can suppress induction of pro-
inflammatory molecules by arterial shear in PJVEC 
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2. MATERIALS AND METHODS 
 
2.1. Isolation and culturing of endothelial cells 
2.1.1. PAEC isolation  
Porcine aortas was obtained from a local abattoir and kept in transport medium consisting 
of Hanks’ balanced salt solution (HBSS), 0.5% penicillin-streptomycin, 0.5% gentamicin 
and 0.5 % sodium-pyruvat. To isolate the PAEC the aortas were first dissected and 
cleansed in a sterile laminar air flow hood to get rid of the surrounding adipose tissue. 
One end of the aorta was clamped shut using one or more surgical scissor clamps and all 
the branches were tied off using surgical thread. The aorta was filled with collagenase 
(0.5mg/ml) in HBSS (40 ml) and clamped shut at both ends. The aorta was covered in 
foil and incubated for 15 minutes at 37 ˚C. The collagenase was flushed through and put 
into a 50 ml tube. The aorta was washed once with 10ml HBSS w/o and this wash was 
added to the tube. The tube was spun at 1200 RPM and the supernatant was discarded. 
The pellet was resuspended in another 50 ml of HBSS and spun once more at 1200 RPM. 
This time the pellet was resuspended in 5 ml complete M199 media (Sigma). The cell 
suspension was transferred into at T25 flask coated with 1% gelatin and incubated at 37 
˚C. After approximately 24 hours the medium was changed to remove dead cells and 
other debris. After approximately 2-3 days the T25 flask was confluent and ready for 
splitting.  
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2.1.2. PJVEC isolation  
Porcine jugular veins were obtained from a local abattoir and the cell harvesting from the 
veins was done in the same manner as with the PAEC, although the veins are far more 
fragile and has to be handled more gently than the aortas. After approximately 24 hours 
the medium was changed to remove dead cells and other debris. In the following weeks 
the medium was changed on the cells every 2-3 days. To get a confluent T25 flask took 
approximately 6 weeks of gentle care.  
 
We experienced some complications in culturing the PJVEC and we lost several of our 
cultures. This was mainly due to infections. In addition, incidents of foot and mouth 
disease in the UK made it difficult to obtain new porcine tissue at times from which we 
could harvest more cells. This, and the fact that it took approximately 6 weeks for the 
cells to reach confluency, made it difficult to get enough cells for our experiments during 
this project. 
 
2.1.3. Complete medium for porcine EC 
Complete medium for porcine EC was made by adding 100 ml heat inactivated fetal calf 
serum (FCS, Sigma), 5 ml L-glutamin (200 mM, Sigma) and 5ml penicillin-streptomycin 
(10,000 units/ml penicillin and 10 mg/ml streptomycin (Sigma)) to a 500 ml bottle of 
medium M199 (Sigma). Immediately prior to use, 10 µl/ml of ECGF (Endothelial cell 
growth factor from bovine neural tissue (Sigma) dissolved in 1000 IE/ml Heparin 
(Monoparin)) was added to complete the medium. 
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2.1.4. Passaging PAEC 
After the cells reached 80 - 90 % confluency, usually after 2-3 days, the cells were split 
1:3. The medium was removed by a vacuum suction pump, and the cells were briefly 
rinsed with HBSS w/o. Trypsin-EDTA (2 ml in a T25 flask, 5 ml in a T75 flask) was 
added to the flasks and they were incubated for about 2-3 minutes at 37 ˚C. Trypsin is a 
serine protease which is used to resuspend the cells in cell-culture flasks. It acts by 
hydrolysing the peptides that adheres the cells to the gelatin base in the flask. After the 
incubation with trypsin the flasks were tapped on the side to lift the cells into suspension. 
The suspension was then transferred into a 50 ml tube. The flask was washed once with 
HBSS w/o and this wash was added to the tube. The tube was filled ad 50 ml with HBSS 
w/o and spun down at 1200 RPM. The supernatant was discarded and the pellet 
resuspended in HBSS w/o and spun once more at 1200 RPM. The supernatant was once 
more discarded and this time the cell pellet was resuspended in complete media (5 ml per 
flask). The cell suspension was homogenized by pipetting with a 10 ml pipette, and then 
divided into fresh flasks coated with 1 % gelatin. 
 
2.1.5. Passaging PJVEC 
After the cells reached 80 - 90 % confluency, usually after approximately 6 weeks for the 
initial T25 flask, the cells were split 1:3. However, after the first passage the cells grew 
faster and usually reached 80-90 % confluency in 4-5 days. The medium was removed by 
a vacuum suction pump, and the cells were briefly rinsed with HBSS. Trypsin-EDTA (2 
ml in a T25, 5 ml in a T75 flask) was added to the flasks and they were incubated for 
about 2-3 minutes at 37 ˚C. After the incubation with trypsin the flasks were tapped on 
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the side to lift the cells into suspension. The suspension was then transferred into a 50 ml 
tube. The flask was washed once with HBSS and this wash was added to the tube. The 
tube was filled ad 50 ml with HBSS and spun down at 1200 RPM. The supernatant was 
discarded and the pellet resuspended in HBSS and spun once more at 1200 RPM. The 
supernatant was once more discarded and this time the cell pellet was resuspended in 
complete media (5 ml per flask). The cell suspension was homogenized by pipetting up 
and down with a 10 ml pipette, and then divided into fresh flasks coated with 1 % gelatin. 
 
2.2. Cytodyne parallel-plate flow chamber loop 
To mimic the effects of arterial shear we used a Cytodyne parallel-plate flow chamber 
loop (as shown in Figure 2.1). The apparatus consist of two reservoirs, situated one above 
the other and with a flow chamber (Figure 2.2) positioned in between them. Medium is 
pumped into the upper reservoir and flow is driven though the chamber by the hydrostatic 
pressure head created by the vertical distance between the reservoirs (Frangos et al., 
1987). The parts of the apparatus was cleaned and perfused with water before it was 
autoclaved. The apparatus was assembled in a laminar flow hood and placed in a 
workbench heated to 37 ˚C and connected to a gassing system that maintained a 5 % CO2, 
95 % air atmosphere. The medium used in the experiments was M199 (Sigma), 0.5 % L-
glutamin (20mM, Sigma), 0.5 % penicillin-streptomycin(10,000 units/ml penicillin and 
10 mg/ml streptomycin (Sigma)). 
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Figure 2.1 Drawing of small volume flow loop. (1) upper reservoir, (2) lower reservoir, (3) overflow 
manifold, (4) filtered humidified 95% air + 5% C02 input, (5) gas outlet, (6) flow chamber, (7) gasket, (8) 
slide with cell monolayer, (9) microscope objective, (10) vacuum, (11) sampling port, 12) roller pump, (13) 
PFA teflon tubing, (14) constant pressure head, and (15) flow probe (Frangos et al., 1987). 
 
 
Figure 2.2 Parallel plate flow chamber. The polycarbonate plate, the gasket (G), and the glass slide (H) 
with the attached cells are held together by a vacuum (C), forming a channel of parallel plate geometry. 
Medium enters at entry port (A), through slit (E), into the channel, and exits through slit (F), and exit port 
(B). Entry port (A) also serves as a trap for bubbles, which can be removed through valve (D) (Frangos et 
al., 1987) 
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Porcine EC were cultured on gelatin coated glass slides for 48 hours before they were 
mounted in the parallel-plate flow chamber. In our experiments we exposed the cells to 
12 dynes/cm2 shear stress, which is equivalent to arterial shear. We exposed the cells to 
flow for 0, 30, 90, 120 or 240 minutes. 
 
2.3. Lysing of EC and protein extraction 
Protein lysates were obtained from cells by using the Nucbuster protein extraction kit 
(Novagen) and the following protocol: The cells were gently rinsed twice with ice cold 
PBS (phosphate buffered saline (Gibco)) and the PBS was removed by a vacuum suction 
pump. 150 µl of the lysis buffer (NucBuster Reagent 1) was added to the monolayer of 
cells and the slide was incubated on ice for 5 minutes. After incubation the cells were 
scraped off the slide using a cell scraper and transferred into a 1,5ml eppendorf tube. The 
suspension was vortexed for 15 seconds and incubated on ice for another 5 minutes. This 
was repeated twice before the suspension was spun down at 16 000 RPM at 4 ˚C.  The 
supernatant now contained the cytoplasmic proteins, and was transferred into a fresh 
eppendorf tube and stored at –80 ˚C. The pellet was used to make nuclear protein lysates 
as follows; First it was resuspended in 1 µl protease inhibitor cocktail (supplied with the 
NucBuster kit), 1 µl of DTT (supplied with NucBuster kit) and 75 µl of NucBuster 
Reagent 2. It was then vortexed for 15 seconds and incubated on ice for 5 min. This was 
repeated twice before the suspension was spun down at 16 000 RPM for 10 minutes at 4 
˚C. The supernatant now contained the nuclear protein extract. It was transferred into a 
fresh eppendorf tube and stored in the –80 ˚C freezer.  
 
MATERIALS AND METHODS 
 
 
37 
2.3.1. Protein quantification using BioRad DC protein assay kit 
The assay is based on a colorimetric reaction between the protein and an alkaline copper 
tartrate solution and Folin reagent. The colorimetric reaction consist of two steps: first the 
protein and copper will form a complex in alkaline solution, which in turn reduces the 
folin reagent producing a blue colour (BioRad homepage).  
 
The bovine serum albumin (BSA) stock solution is 300 mg/ml in PBS. We diluted the 
BSA into two working solutions at 10 mg/ml and 1 mg/ml before we made a standard 
curve according to the following table: 
 
Table 2.1 BSA protein concentration standard curve 
  Volume needed (µl) 
 
Sample 
BSA 
concentration 
(mg/ml) 
Standard 
dilution 
buffer (PBS) 
BSA 
1 mg/ml 
BSA 
10 mg/ml 
Total 
volume 
(µl) 
1 0.0 12.0 0.0 0.0 12.0 
2 0.1 10.8 1.2 0.0 12.0 
3 0.2 9.6 2.4 0.0 12.0 
4 0.4 7.2 4.8 0.0 12.0 
5 0.6 4.8 7.2 0.0 12.0 
6 0.8 2.4 9.6 0.0 12.0 
7 1.0 0.0 12.0 0.0 12.0 
8 1.3 14.0 0.0 2.0 16.0 
9 1.5 17.0 0.0 3.0 20.0 
 
 
The BioRad protein assay kit contains 3 reagents: A, B and S. We made a solution A’ 
which consist of 20 µl Reagent S in 1 ml of Reagent A. Using a 96 well plate we added to 
each well 5 µl sample/standard, 25 µl solution A’ and 200 µl Reagent B. Each sample or 
standard were ran in duplicates. We read the plate in a UV spectrophotometer at 750 nm 
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within 15 minutes. Sometimes the samples were oversaturated and had to be diluted to 
fall within the concentrations covered by the standard curve. 
 
The readout from the spectrophotometer stated the samples’ optical density (OD) values. 
The values from the BSA standard samples were used to calculate a standard curve in a 
Microsoft Excel work sheet by using the linear equation y = ax + b, where y is the OD 
(absorbance) and x is the concentration. The values for a and b are constants which are 
given when the standard curve is drawn in the work sheet. Since the only unknown is the 
concentration the final equation is this:  
(dilution factor) * concentration = (OD-b)/a 
This is the equation used to calculate the samples protein concentration.  
 
2.4. Protein expression analysis by western blotting 
2.4.1. SDS Page gel electrophoresis 
SDS Page electrophoresis allows separation of proteins by their molecular weight. 
Sampled proteins become covered in the negatively charged SDS and move to the 
positively charged electrode through the acryl amide mesh of the gel. Smaller proteins 
migrate faster than larger proteins and the proteins are thus separated according to size.  
 
15 µl of each sample was transferred into a 1.5 ml eppendorf tube. Loading buffer was 
prepared by having 180 µl NuPage LDS 4X Loading Buffer (Invitrogen) into an 
eppendorf and adding 20 µl DTT 1M. 5 µl of this mix was added to each sample and the 
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tubes were put on a heating block set to 95 ˚C for 5 minutes to denature the proteins. The 
tubes were then spun down for 30 seconds to retrieve the condensation. 
 
A gel (NuPAGE® Novex 4-12% Bis-Tris Gel 1.0 mm, 12 wells (Invitrogen)) placed in a 
electrophoresis tank filled with running buffer (40 ml of NuPage Mops SDS Running 
buffer 20 X added to 760 ml sterile water) was loaded with the sample-loading buffer mix 
(20 µl per well). One well was loaded with 10 µl marker (SeeBlue Plus2® Prestained 
standard (1x) (Invitrogen)). The electrophoresis was run for 1 hour at 200 V. 
 
2.4.2. Transfer 
Transfer was performed using the NuPAGE™ System (Invitrogen). Transfer buffer was 
made, consisting of 850 ml ultrapure water, 50 ml transfer buffer (NuPAGE™ Transfer 
Buffer (20x) (Invitrogen)), 100ml absolute methanol and 1 ml antioxidant (NuPAGE™ 
Antioxidant (Invitrogen)). A PVDF membrane (Immobilon-P Transfer membrane, filter 
type: PVDF, pore size: 0.45 µm (Millipore)) was wetted for 30 seconds in methanol 
(Methanol Microscopy (BDH)) and then washed quickly in the transfer buffer before use. 
Transfer was completed by assembling the gel, membrane, filter paper (Chromatography 
paper, 3mm, CHR, 58x68 cm (Whatman®) (soaked in transfer buffer) and blotting pads 
(soaked in transfer buffer). The transfer was run for 1 hour at 25 V. 
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2.4.3. Blocking and protein detection 
Blocking of non-specific protein binding was achieved by placing the membrane with the 
protein side facing up in a dilute solution of protein (Marvel dried skimmed milk, 1% fat) 
in a 0.1% PBS-Tween solution (1 ml Tween®20 Sigma Ultra (Sigma) in 1000 ml PBS 
(Gibco)). The membrane was left on blocking on a shaker at room temperature for 1 hour. 
After the blocking, the membrane was washed in 0.1 % PBS-Tween 3 times for 5 minutes 
on a rocking platform. 
 
The membrane was then incubated with the primary antibody over night at 4 ˚C on a 
rocking platform (for primary antibody concentrations, see table 2.2) followed by 3 
washes of 5 minutes with PBS-Tween. 
 
Table 2.2 Primary antibodies used in western blotting (diluted in PBS-Tween w/1% skimmed milk) 
Company Primary antibody dilution factor 
New England Biolabs mouse anti-phospho p38 1:1000 
New England Biolabs rabbit anti-p38 1:1000 
New England Biolabs mouse anti-phospho JNK 1:1000 
New England Biolabs rabbit anti-JNK 1:1000 
Santa Cruz biotechnologies rabbit anti-p65 1:1000 
Santa Cruz biotechnologies goat anti-lamin B 1:1000 
 
 
The secondary antibody (horse radish peroxidase (HRP) - conjugated) was added to the 
membrane and left on for 45 minutes on a rocking platform (table 2.3). The membrane 
was then washed 3 times 5 minutes to get rid of excess antibody.  
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Table 2.3 Secondary HRP-conjugated antibodies used in western blotting (diluted in PBS-Tween) 
Company Secondary antibody dilution factor 
Dako Polyclonal goat anti rabbit 1:10 000 
Dako Polyclonal rabbit anti mouse 1:10 000 
Dako Polyclonal mouse anti goat 1:10 000 
 
 
3 ml of each of the two Western Lightning Chemoluminescence reagents (PerkinElmer) 
was added to the membrane for 2 minutes to enhance the luminescence. The membrane 
was quickly dried between two sheets of filter paper and covered in saran wrap foil. 
 
The membrane was brought into the dark room and placed in a light sealed cassette with 
photographic film (KODAK®BioMax Light Film 18x24 cm Light-1 (Sigma-Aldrich)) on 
top and left for appropriate times of exposure. After exposing the film to the 
luminescence, the film was developed using an automated developer (Compact X4 
Automatic X-ray Film Processor (Xograph Imaging Systems)).  
 
2.4.4. Analysing western blots by densitometry 
We analyzed the western blots by densitometry, using the Image-J software. The levels of 
expression of the proteins of interest were given by calculating the ratio of the target 
protein and an internal standard. Levels of active, phosphorylated forms of p38 or JNK in 
the cytoplasm, were normalised by measuring the amount of total p38 or JNK in the 
cytoplasm. Similarly, levels of p65 in the nucleus were normalised by measuring the 
amount of lamin B (a nuclear protein) in the nucleus. 
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2.5. RNA isolation 
 
The RNA was extracted using the RNeasy Mini kit (Qiagen). Untreated, flow treated and 
TNFα treated cells were rinsed briefly with ice cold PBS. The PBS was completely 
aspirated and 350 µl of the denaturing Buffer RLT + BME (β-mercaptoethanol) (10 µl 
BME per 1ml of Buffer RLT) was added to inactivate RNases and to ensure a high yield 
of intact RNA. The cells were disrupted and collected by using a cell scraper and the 
suspension was transferred into a 1.5 ml eppendorf. The sample was homogenized by 
using a syringe and needle (20 gauge, 0.9 mm) and pipetting the suspension up and down 
10 times. Homogenization is important to reduce the viscosity of the suspension and to 
avoid flocculation of RNA. Incomplete homogenization gives significantly reduced yield 
and may lead to clogging of the RNeasy Mini Spin Column.  
 
To the lysed and homogenized cells, 350 µl of 70 % ethanol was added and mixed gently 
using a pipette. This mix was added into a RNeasy spin column placed in a 2 ml 
collection tube and spun down at 10 000 RPM fro 15 seconds. The flow through was 
discarded. To wash the sample 700 µl of RW1 buffer (supplied with kit) was added to the 
column and it was spun down at 10 000 RPM for 15 seconds. The flow through and 
collection tube was discarded. The RNeasy spin column was placed in a new 2 ml 
collection tube, and 500 µl of diluted RPE buffer was added to the column to further 
wash the sample. Then it was spun down at 10 000 RPM for 15 seconds. The flow 
through was discarded and another 500 µl of RPE-ethanol was added to the column. It 
was spun down at 10 000 RPM for 2 minutes to dry the column and thereby avoid ethanol 
carryover that would contaminate the sample. The collection tube and flow through was 
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discarded and the column was placed in a 1.5 ml collection tube. 40 µl of Rnase-free 
water was added directly to the spin column silica-gel membrane and it was spun down at 
10 000 RPM for 1 minute to elute the pure RNA. The RNA was stored at – 80 ˚C. 
 
2.5.1. Quantification of RNA using UV spectrophotometer 
The spectrophotometer (Ultrospec®3000 UV/Visible Spectrophotometer (Pharmacia 
Biotech)) was programmed to read the optical absorbance at 260 nm and 280 nm. The 
approximate RNA concentration can be calculated by the ratio between the two 
measurements at 260 and 280 nm. The quartz cuvette was washed with ultra pure water 
and dried with a paper towel. The RNA samples were diluted 1:100 in RNase-free water 
and mixed well. A sample of 100 µl ultra pure water was used as a blank sample to 
calibrate the spectrophotometer. 100 µl of each sample was in turn added to the cuvette 
and analysed, the cuvette was rinsed with 100 µl of ultra pure water between each 
sample. 
 
2.5.2. Complementary DNA (cDNA) 
cDNA was synthesised from mRNA using the reverse transcriptase enzyme. Given the 
RNA concentration in each sample we calculated the amount needed for 1 µg of RNA 
and adjusted the volume to 15 µl with ultra pure water. I then added 1 µl oligo dT and 1 
µl dNTP to each sample. Then the tubes were put on a heating block set to 65 ˚C for 5 
minutes and were put directly onto a tray of ice to cool down after heating. To each tube 
5 µl 5x First strand buffer, 2 µl DTT and 1 µl SuperScript II was added. The tubes were 
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put onto a heating block set to 42 ˚C for 45 minutes then rising to 70 ˚C for 15 minutes to 
make the finished cDNA. 
 
2.6. Quantitative real-time polymerase chain reaction (PCR) 
 
2.6.1. Real time RT-PCR principle 
The real time PCR is an effective method for quantifying levels of mRNA expression. It 
is based on repeating cycles of 3 stages (Figure 2.3): denaturation, annealing and 
polymerisation/elongation. In the denaturation step the reaction is heated to 94-98 ˚C to 
heat inactivate most enzymes (but not the heat stable iTaq DNA polymerase) and to 
denature the DNA into single strands. After the denaturation step the reaction is quickly 
cooled to prevent reformation of the DNA strands. Yet, because of their small size the 
primers anneal to their complementary single strands. After annealing the temperature is 
raised to the polymerisation optimum temperature, which for iTaq polymerase is 70-74 
˚C.  During each cycle the transcripts will theoretically be amplified 2 fold, and by 
repeating the cycle over and over the amplification will be logarithmic, where the amount 
of transcript will be 2n, where n is the number of cycles. Eventually the reaction will 
reach a plateau phase and level out. There is a linear relationship between the amount of 
DNA and the cycle number. 
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Figure 2.3 The PCR cycle. Diagram of PCR reaction to demonstrate how amplification leads to the 
exponential growth of a short product flanked by the primers. Schematic drawing of the PCR cycle. 1: 
Denaturing at 96°C. 2: Annealing at 68°C. 3: Elongation at 72°C (P=Polymerase). The first cycle is 
complete. The two resulting DNA strands make up the template DNA for the next cycle, thus doubling the 
amount of DNA duplicated for each new cycle (Internet reference 4) 
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2.6.2. RT-PCR plate setup 
cDNA was diluted 1:10 with ultra pure water to working concentration. The primers 
stock concentration was 100 µM and they were diluted 1:10  with ultra pure water to the 
working concentration 10 µM. For each gene we made up a master mix with the 
following constituents and amounts per well: 
 
12.5 µl Sybr Green Jumpstart Readymix 
6.5 µl ultra pure water 
0.5 µl forward primer 
0.5 µl reverse primer 
 
The reaction was set up in an optical reaction 96 well plate (BioRad), and samples were 
run in triplicates for each gene. To each well 5 µl of working concentration sample 
(cDNA) and 20 µl of the mastermix was added. When the pippeting was complete the 
plate was covered with optical adhesive film and the plate was vortexed for 15 seconds 
before it was spun down at 1000 RPM for 1 minute. The plate was then mounted into the 
BioRad iCycler ®. 
 
2.6.3. Primer design 
The primers define which fragments of DNA that are to be amplified and are thus of 
crucial importance to get a successful result when using real time PCR. The primers are 
short strands of nucleic acids that are perfect complements to the starting point of the 
gene sequence that is to be amplified. Since DNA polymerases (iTaq) can only bind to 
double stranded DNA the primers serve as a starting point for replication of the DNA 
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fragment in question. Primers for porcine versions of several pro-inflammatory and anti-
inflammatory genes were designed (table 2.4).  
 
Table 2.4 Primer sequences used in PCR 
Gene Forward sequence Reverse sequence 
Cyclophilin 5' ATTTGATGATGAGAATTTTATCC -3' 5'-ATGCCCTCTTTCACTTTG-3' 
MCP-1 5'-GTCACCTGCTGCTATACACTTAC-3' 5'-ATCACTGCTTCTTTAGGACACTTG-3' 
IL-8 5'-CACCATGACTTCCAAACTGGC-3' 5'-CTGCTGTTGTTGTTGCTTCTC-3' 
VCAM-1 5'-GTGTGCGAGGGAGTTAATC-3' 5'-CACTAGAGCAGGTCATGTTC-3' 
ICAM-1 5'-ATCAATGGAACCGAGAAG-3' 5'-CACTCTATGCTCACTGTAG-3' 
E-selectin 5'-TTCAAATCCTCCCTTACAC-3' 5'-CATAGAGACCATCAATAGC-3' 
P-selectin 5'-TGAGCCTTGTGTGAAAAG-3' 5'-GTCCATAGAATCCAGAGTAG-3' 
IP-10 5'-CCTGTTAATCCGAGGTCCTTAGAAAA-3' 5'-ATTGTGGCAATGATCTCAACATGT-3' 
MKP-1 5'-GCAAACATACAACTGTTGGCA-3' 5'-TAGATCCTGAAGCAGGTTTGTTT-3' 
XIAP 5'-GAGGAGGGCTAACAGATTGG-3' 5'-GATACCACTTCGCATGCTGT-3' 
Keap-1 5'-CCTCATCGAGTTCGCTTACA-3' 5'-CATTCATGACATGGAGCACA-3' 
Nrf2 5'-AGCAAGTTTGGGAGGAGCTA-3' 5'-GTCGGTTTGGTTTCTGGACT-3' 
A20 5'-AAACGAAATTCCATGCAACA-3' 5’-GCTTCTCCCAGGTCTGGTC-3' 
Cezanne 5'-ACAATGTCCGATTGGCCAGT-3' 5'-ACAGTGGGATCCACTTCACATTC-3' 
 
2.6.4. Detection of products 
In real time PCR the amount of product is assessed at the end of each cycle. This requires 
incorporation of fluorescent labeling, and we used SYBR Green for our detection. SYBR 
Green is a DNA binding dye which exhibits little or no fluorescence while unbound. 
However, during the annealing and elongation steps the dye molecules bind to the double 
stranded DNA and emit light upon excitation (Figure 2.4). In real time PCR, the 
fluorescence is measured at the end of the elongation step in each cycle to monitor the 
increasing amount of DNA. 
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Figure 2.4 Dye incorporation method. (A) During denaturation, unbound SYBR Green I dye exhibits little 
fluorescence. (B) At the annealing temperature, a few dye molecules bind to the double-stranded 
primer/target, resulting in light emission upon excitation. (C) During the polymerization step, more and 
more dye molecules bind to the newly synthesized DNA, and the increase in fluorescence can be monitored 
in real-time. (D) On denaturation, the dye molecules are released and the fluorescence signal returns to 
background (Bustin, 2000) 
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2.6.5. Calculation of transcript levels 
The fluorescence values are recorded at the end of every cycle and represent the amount 
of product amplified to that point in the amplification reaction. The more template cDNA 
present at the beginning of the reaction, the fewer number of cycles it takes to reach a 
point in which the fluorescent signal is first recorded as statistically significant above 
background and this point is defined as the cycle threshold (Ct) (Gibson et al. 1996).  
 
Cyclophilin is a transcript that is constitutively expressed in porcine EC and is commonly 
used as a housekeeping gene in PCR experiments on porcine cells (Dozois et al, 1997).  
Cyclophilin was used as the internal standard to which the samples were normalized. 
∆Ct = Ct (target gene) – Ct (housekeeping gene) 
The comparative Ct (∆∆Ct) method was used to quantify the relative changes in mRNA 
expression in treated samples compared to a untreated control sample (baseline).  
∆∆Ct = ∆Ct (sample) – ∆Ct (control) 
Then the ∆∆Ct values were transformed to absolute values: 
Comparative transcription level = 2-∆∆Ct 
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2.7. NF-κB p65 ELISA kit (TransAm) 
The kit contains strips of wells coated with an immobilized oligonucleotide that is 
recognized by p65. p65 in the sample will specifically bind to the oligonucleotide and by 
using an antibody that is directed against p65 the NF-κB dimer is detected. Addition of a 
HRP-conjugated secondary antibody makes quantification by spectrophotometry 
possible. 
 
Nuclear protein lysates from PAEC treated with 0, 30 or 90 minutes of flow were tested 
in duplicates with the Trans Am NF-κB p65 ELISA kit according to the manufacturers 
protocol. The colorimetric readout was quantified using a spectrophotometer 
(Ultrospec®3000 UV/Visible Spectrophotometer (Pharmacia Biotech)) at 450 nm with a 
reference wavelength of 655 nm.  
 
2.8. Immunohistochemistry (IHC) on cultured porcine EC 
Porcine EC were grown as monolayers on glass coverslips (VWR) placed in a 6 well 
plate. After 48 hours incubation the cells were stimulated with 0, 15 or 30 minutes TNF-α 
(10 ng/ml). Alternatively porcine EC were grown on glass slides (VWR) and after 48 
hours of incubation the cells were exposed to 0, 30 or 90 minutes of flow. 
2.8.1. Staining for p65 
After treatment (with TNFα or flow) the slides/coverslips were rinsed briefly with PBS. 
The PBS was aspirated and 4% paraformaldehyde was applied for 10 minutes to fixate 
the cells. After fixation, the cells were rinsed 3 times with PBS. The cells were then 
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permeabilized using 0.1% triton X100/PBS for 4 minutes. This stage was repeated before 
the slides/coverslips were rinsed 3 times using 0.5 % BSA/PBS. The cells were blocked 
for 30 minutes using 0.5 % BSA/PBS (blocking buffer).  
 
The primary antibody (NF-κB p65 (C-20) rabbit polyclonal 100 µg/ml, Santa Cruz 
Biotechnology) was diluted 1:200 in the blocking buffer and added to the cells. The slides 
were incubated with the primary antibody for 1 hour, before the slides/coverslips were 
rinsed with blocking buffer twice and washed 3 times for 10 minutes also with the 
blocking buffer. 
 
The cells were then incubated with the secondary antibody (Alexa Fluor 568 goat anti-
rabbit 2mg/ml, Molecular Probes) (diluted 1:300 in blocking buffer) and a FITC-
conjugated DBA lectin antibody (Fluorescein labeled Dolichos Biflorus Agglutinin, 
Vector Laboratories) (diluted 1:100 in blocking buffer) for 45 minutes. After this 
incubation the cells were rinsed in blocking buffer twice and washed 3 times for 10 
minutes also in blocking buffer. Finally the slides/coverslips were rinsed once with PBS 
and once with sterile water. 
 
The coverslips were mounted onto glass slides using Aqua Poly/Mount (Polysciences 
Inc). Similarly the coverslips were mounted onto the glass slides, and the slides were 
photographed and analyzed using a confocal LSM microscope (Zeiss LSM 510 META). 
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3. RESULTS 
 
3.1. Validation of the phenotype of cultured cells 
 
First we had to validate that the cells we isolated from porcine aortas and porcine jugular 
veins by collagenase treatment, are in fact endothelial cells. To achieve this we performed 
phase contrast microscopy, immuno fluorescence confocal microscopy and flow 
cytometry. Phase contrast microscopy revealed that both PAEC and PJVEC assume a 
“cobble stone” morphology in culture (Figure 3.1, upper panel). The cells could be 
stained with FITC DBA lectin (Figure 3.1, centre panel) with a positive marker of EC. It 
is known that endothelial cells express the surface protein CD31 (PECAM-1), smooth 
muscle cells however, does not express this protein. CD31 is therefore frequently used as 
a marker of endothelial cells. We observed by immunostaining and flow cytometry that 
>90 % PAEC and PJVEC expressed CD31 (Figure 3.1, lower panel). In conclusion, the 
PAEC and PJVEC cultures used in my study were indeed of endothelial origin. 
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FITC-DBA lectin
Phase contrast
PAEC PJVEC
anti-CD31
 
Figure 3.1 Porcine EC. Cells cultured on gelatin-coated coverslips were fixed with 4% paraformaldehyde 
for 15mins before analysis by phase contrast microscopy (upper panel). Alternatively, fixed cells were 
stained using FITC-conjugated DBA lectin (green) and counterstained with To-Pro 5 iodide to identify 
nuclei (pink) followed by laser-scanning confocal microscopy at X40 magnification (LSM 510 META, 
Zeiss) (middle panel). Porcine aortic endothelial cells (PAEC) were stained for CD31(PECAM-1) using 
LCI-4 primary antibodies and FITC-conjugated secondary antibodies before analysis by flow cytometry. 
Alternatively, cells were incubated with isotype-matched control antibodies (lower panel) (Data from 
M.Zakkar).  
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3.2. Endothelial activation in response to TNFα   
We assessed pro-inflammatory activation of PAEC and PJVEC in response to TNFα 
(Figure 3.2, left upper panel). Neither of the populations expressed E-selectin or VCAM-
1 constitutively. TNFα induced E-selectin surface expression in approximately 50 % of 
the PAEC following 4 hours treatment, which decreased to approximately 25 % at 24 
hours.  Similarly, TNFα induced E-selectin expression in approximately 60 % of the 
PJVEC at 4 hours and 25 % at 24 hours of treatment (Figure 3.2, right upper panel).  In 
PAEC, TNFα induced VCAM-1 expression in approximately 70 % of the cells after 2 
hours stimulation which decreased to approximately 60 % at 24 hours of treatment. TNFα 
induced VCAM-1 surface expression in approximately 70 % PJVECs at 2 both 2 and 24 
hours of treatment. 
 
I conclude that both PAEC and PJVEC express E-selectin and VCAM-1 in response to 
TNFα and that the kinetics of the response is broadly similar between the cell types. 
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Figure 3.2 Porcine EC in response to TNFα  Flow cytometry Cultured cells were stimulated with TNFα 
(10ng/ml) and, surface expression of E-selectin or VCAM-1 was quantified by immunostaining using anti-
E-selectin (mAb 1.2B6) or anti-VCAM-1 antibodies (mAb 10.2C7) and FITC-conjugated secondary 
antibodies followed by flow cytometry. Positive cells were identified as those with greater fluorescence 
than cells incubated with isotype-matched control antibodies/FITC-conjugated secondary. Values represent 
the percentage of positive cells at each time point. (Data from M.Zakkar) 
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3.3. Acute laminar flow (12 dynes/cm2) induces inflammatory 
chemokines and adhesion molecules 
My initial experiments were on cultured monolayers of PAEC and PJVEC. The cells 
were plated on gelatin coated glass slides for 48 hours before they were either mounted in 
a vacuum sealed parallel flow chamber system or left under static conditions in an 
incubator (37 ˚C, 5% CO2, 95% O2). The cells were exposed to either 0, 2 or 4 hours of 
laminar flow with 12 dynes/cm2 shear stress. After 0, 2 or 4 hours of flow the cells were 
briefly rinsed in cold PBS before the cells were lysed and total RNA was extracted. 
cDNA was synthesized using the mRNA extracts, and we used this cDNA to run 
comparative RT-PCR looking firstly at pro-inflammatory genes. Porcine versions of IL-8, 
MCP-1, IP-10, E-selectin, P-selectin, VCAM-1, ICAM-1 and cyclophilin primers were 
designed. The transcript levels were normalised to the housekeeping gene cyclophilin.  
 
3.3.1. Chemokine expression 
We measured transcript levels of three chemokines: IL-8, MCP-1 and IP-10 in static cells 
or cells exposed to shear stress. Our experiments show that MCP-1 and IL-8 are 
significantly upregulated at the mRNA level in PJVEC exposed to arterial flow for 2 and 
4 hours (Figure 3.3, right side upper and centre panels).  In contrast 2 hour or 4 hour 
laminar flow had little or no effect on IL-8 or MCP-1 in PAEC (Figure 3.3, left side 
upper and centre panels). This is an interesting difference between the porcine aortic EC 
and the porcine jugular vein EC which suggest that the PJVECs are hypersensitive to 
acute shear stress. IP-10 transcript levels remain relatively unchanged in PJVEC after 
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flow treatment for both 2 and 4 hours (Figure 3.3, lower right panel). In PAEC our data 
show that 2 hours of shear stress downregulate the transcription of IP-10, while at 4 hours 
of flow the transcript level is increasing towards the basal level (Figure 3.3, lower left 
panel). 
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Figure 3.3 Chemokine induction. PAECs and PJVEC were cultured on glass slides for 48 hours before 
they were mounted onto a laminar flow chamber and exposed to flow for the indicated times. Quantitative 
RT-PCR was performed to analyze relative amounts of the genes. The transcript levels shown are 
normalised to the housekeeping gene cyclophilin and all the samples are normalised to the static control (0 
hours flow) (n=3). 
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3.3.2. Adhesion molecule expression 
Next I examined the expression of two selectins; E-selectin and P-selectin, and two other 
adhesion molecules; VCAM-1 and ICAM-1 in flow-conditioned EC. 
 
Our data show that E-selectin is transiently upregulated by acute flow in PJVEC, with a 
peak at 2 hours (3.5-fold) of shear stress (Figure 3.4, upper right panel). Comparatively, 
E-selectin seems to be slightly downregulated by acute laminar flow in PAEC (Figure 
3.4, upper left panel).  
 
P-selectin is down regulated in both PAEC and PJVEC by acute shear stress (Figure 3.4, 
lower panels). 
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Figure 3.4 Transcription of selectins in response to flow. PAEC and PJVEC were cultured on glass 
slides for 48 hours before they were mounted onto a laminar flow chamber and exposed to flow for the 
indicated times. Quantitative RT-PCR was performed to analyze relative amounts of the genes. The 
transcript levels are normalised to the housekeeping gene cyclophilin and all the samples are normalised to 
the static control (0 hours flow) (n=3). Statistics were done using paired student’s t-test. 
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Our experiments suggest that neither VCAM-1 (Figure 3.5, upper panel) nor ICAM-1 
(Figure 3.5, lower panel) mRNA levels are upregulated by acute laminar flow in either 
PAEC or PJVEC. 
 
 
 
 
 
 
 
 
Figure 3.5 Adhesion molecule transcripts. PAEC and PJVEC were cultured on glass slides for 48 hours 
before they were mounted onto a laminar flow chamber and exposed to flow for the indicated times. 
Quantitative RT-PCR was performed to analyze relative amounts of the genes. The transcript levels are 
normalised to the housekeeping gene cyclophilin and all the samples are normalised to the static control (0 
hours flow) (n=3).   
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3.4. MAP-kinase activation 
We suspected that the differences in gene expression in PAEC and PJVECs in response 
to acute laminar flow might be due to differences in the level of activation of the MAP-
kinase and the NF-κB pathways. To investigate the underlying mechanisms of the gene 
expression we focused on the p38 and JNK MAPK pathways and finally we looked at 
NF-κB. 
 
3.4.1. p38 
To assess whether acute flow altered the level of p38 activation in PAEC and PJVEC we 
performed western blot analysis on protein lysates obtained from flow experiments where 
we used the Cytodyne parallel flow chamber loop. The cells were cultured on glass slides 
as previously shown, for 48 hours. The cells were then exposed to either static conditions 
or laminar flow for 30 or 90 minutes. TNFα (10 ng/ml) treatment was used as the positive 
control on slides under static conditions. Our group routinely use the primary antibodies 
(total p38 and phosphorylated p38 (New England Biolabs)), and they are known to 
specifically recognize all the p38 isoforms.  
 
Western blotting revealed that acute flow did not alter p38 activation in PAEC (Figure 
3.6, left hand panels). However in PJVEC we observed that p38 was activated in response 
to flow (Figure 3.6, right panel). This increase in p38 MAPK activation in PJVEC, 
although modest, may be an important factor in explaining PJVEC hypersensitivity to 
acute laminar flow at arterial shear. Because this experiment was only done once for the 
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PJVEC and twice for the PAEC this needs to be investigated further before firm 
conclusions may be drawn. 
 
 
 
                                              PAEC                               PJVEC 
 
Figure 3.6 p38 activation ito flow. The cells were cultured as monolayers on glass slides for 48 hours 
before they were exposed to laminar flow for the indicated times. The cells were lysed using the NucBuster 
kit and the protein concentration for each sample was calculated using a UV spechtrophotometer. We added 
equal amounts of protein to each well and the blots were developed using Western Lightning 
chemoluminescense (upper panel). The densitometry was calculated using Image-J software and the y-axis 
is showing the phosphorylated p38 / total p38 ratio (lower panel). 
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3.4.2. JNK 
As with the p38 MAPK experiments we performed western blots on protein lysates from 
cells exposed to laminar flow or static contidions to assess the kinetics of JNK activation 
in cultured PAEC and PJVEC. The JNK antibodies (total and phosphorylated JNK, both 
from New England Biolabs) are known to specifically bind to JNK-1/2 (46 kDa and 54 
kDa) protein. We then applied the densitometry technique (Image-J software) to quantify 
the activation.  
 
JNK is transiently activated by acute laminar flow in PAEC with a peak at 30 minutes 
(Figure 3.7, left panel). However in PJVEC, JNK activation by arterial flow is prolonged 
when compared to the PAECs and the peak is at 90 minutes (Figure 3.7, right panel). This 
is an interesting observation that may explain the induction of pro inflammatory 
transcripts in PJVEC in response to acute laminar flow at arterial shear. 
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Figure 3.7 JNK activation in response to flow. The cells were cultured as monolayers on glass slides for 
48 hours before they were exposed to laminar flow for the indicated times. The cells were lysed using the 
NucBuster kit and the protein concentration for each sample was calculated using a UV 
spechtrophotometer. We added equal amounts of protein to each well and the blots were developed using 
Western Lightning chemoluminescense (upper panel). The densitometry was calculated using Image-J 
software and the y-axis is showing the phospho JNK / total JNK ratio (lower panel) (n=2) Statistics done 
using a paired student’s t-test. 
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3.5. NF-κB  p65 
I investigated NF-κB activation in response to acute shear stress using monolayers of 
PAEC and PJVEC plated onto glass slides.  Initially I performed western blotting on 
nuclear lysates using anti-p65 or anti-lamin B antibodies (anti-lamin B antibody served as 
a loading control for nuclear proteins).  
 
My data revealed that p65 translocated to the nucleus after approximately 30 minutes of 
laminar flow and was increased further at 90 minutes in PAEC (Figure 3.8.A, left panel). 
Western blotting of PJVEC lysates gave complicated results. On face value, it appears 
that p65 is present in nuclear lysates for static and flow-treated PJVEC. However, the 
levels of lamin B (nuclear protein) are very low. This suggests that the lysates may be 
“contaminated” with high levels of cytosolic material. Due to these technical difficulties 
it is impossible to draw firm conclusions from this experiment. Thus we approached the 
question of p65 activation in porcine EC in a different manner, by applying the 
immunohistochemistry (IHC) technique and analyze the cells by confocal laser-scanning 
microscopy (LSM) (section 3.5.1 and 3.5.2 below). 
 
To confirm the p65 nuclear translocation in PAEC in response to laminar flow we also 
performed an ELISA quantification with a kit from Trans Am (Figure 3.8.B, left panel). 
We used nuclear lysates obtained in the same manner as the lysates for the previously 
shown western blots (Nucbuster). Due to before mentioned complications in culturing 
PJVECs, we did not have any protein lysate available to do these experiments for the 
venous endothelial cells.   
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Figure 3.8 NF-κB activation in response to flow. The cells were cultured as monolayers on glass slides 
for 48 hours before they were exposed to laminar flow for the indicated times.  The cells were lysed using 
the NucBuster kit and the protein concentration for each sample was calculated using a UV 
spechtrophotometer. The nuclear fraction of the protein lysate was used in the western blot analysis and the 
constitutive nuclear protein lamin B was used as a loading control. The blots were developed using Western 
Lightning chemoluminescense. The densitometry was calculated using Image-J software and the y-axis is 
showing the p65/lamin B ratio (n=2) (A). Alternatively TransAm ELISA kit was used to quantify nuclear 
p65. The optical density was measured in a UV spectrophotometer (n=2) (B) Statistics were done using 
paired student’s t-test.  
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3.5.1. p65 response to TNFα using immunohistochemistry 
Cells were plated on glass slides and left for 48 hours before they were treated with flow 
for 0, 30 and 90 minutes. We then fixed the cells in 4 % paraformaldehyde and proceeded 
with the staining protocol. We wanted to look at the NF-κB activation and thus stained 
for p65. We included the FITC-conjugated DBA as a marker for endothelium. The slides 
were then analyzed by confocal LSM microscopy. 
 
I assessed the response of PAEC and PJVEC to TNF-α to ensure that the technique was 
adequate. In ustimulated cells, p65 was localised to the cytoplasm in both PAEC and 
PJVEC (Figure 3.9). This supports our previous PAEC data (western blots and ELISAs) 
and our suspicion that the PJVEC western blot analysis was flawed. Upon 15-30 minutes 
of stimulation with TNFα, p65 clearly concentrates within the oval shaped nucleus of the 
PAEC and PJVEC (Figure 3.9; compare centre and lower panels with upper panels). Thus 
p65 translocates to the nucleus in both cell types in response to TNFα. 
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Figure 3.9 TNFα induces p65 translocation in porcine EC. Confocal LSM microscopy (LSM 510 
META, Zeiss, 40X magnification). The cells were cultured as monolayers on glass slides for 48 hours 
before they were stimulated with TNF-α for the indicated times. Then the cells were stained using rabbit 
anti- p65 primary antibody (Santa Cruz) and UV fluorescent 568nm anti-rabbit secondary antibody (red) 
and FITC-conjugated DBA antibody (green) (n=1).  
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3.5.2. p65 response to laminar flow 
We next examined the p65 response  in PAEC and PJVEC exposed to laminar flow. 
 
Upon exposure to laminar flow (12 dynes cm2) for 30 minutes, p65 was partly located in 
the nucleus and partly in the cytoplasm in both PAEC and PJVEC (Figure 3.10; compare 
centre and lower panels with upper panels). This is consistent with the previous data for 
PAEC (western blots and ELISAs (Figure 3.8.A and 3.8.B) which indicated that NF-κB 
can be activated by flow in these cells). After 90 minutes of laminar flow, p65 was 
further concentrated in the nucleus of PJVEC. Unfortunately we do not have data for 
PAEC exposed to laminar flow for 90 minutes, because of technical complications in this 
experiment. In summary, acute laminar flow triggered nuclear localisation of NF-κB in 
both PAEC and PJVEC. Put together, our data therefore imply that PAEC and PJVEC 
respond in a similar manner to acute laminar flow in the respect of p65 activation.  
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Figure 3.10 Flow induces p65 translocation in porcine EC. Confocal LSM microscopy (LSM 510 
META, Zeiss, 40X magnification). The cells were cultured as monolayers on glass slides for 48 hours 
before they were treated with laminar flow in the Cytodyne flow loop for the indicated times. Then the cells 
were stained using rabbit anti- p65 primary antibody (Santa Cruz) and UV fluorescent 568nm anti-rabbit 
secondary antibody (red) and FITC-conjugated DBA antibody (green)  (n=1). 
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3.6.  Cytoprotective and anti-inflammatory transcription is induced by 
acute flow 
Our experiments suggest that PJVEC show increased activation of MAPKs and elevated 
transcription of pro-inflammatory genes in response to laminar flow compared to PAEC 
(Figure 3.3 and Figure 3.4). We hypothesised that PAEC may be more resistant to the 
pro-inflammatory effects of acute laminar flow compared to PJVEC due to elevated 
expression of negative regulators of inflammation such as MKP-1, Cezanne, XIAP, 
Keap-1, Nrf2 and A20. Comparative real time PCR was used to assess the level of each 
of these transcripts in static EC, cells exposed to laminar flow for 4 hours and in cells 
exposed to TNF-α for 2 hours (as a positive control for expression) (Figure 3.11 and 
Figure 3.12) 
 
We observed considerable variation between experiments in the expression levels of 
several molecules in static PAEC and in flow treated or TNFα treated cells. The reasons 
for this are unclear but it is plausible that they may relate to differences in the confluency, 
passage number or genetics of the primary EC used. Nevertheless, several reproducible 
observations could be made which are described below. 
 
For PAEC the experiments were performed 3 times (n=3), but for the PJVEC the 
experiments was only done once (n=1) due to complications encountered in culturing the 
cells during the later stages of the project.  
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3.6.1. Quantitative RT PCR 
Our real time PCR data suggest that MKP-1 transcripts were upregulated approximately 
8-fold by acute laminar flow in PAECs, but not in PJVECs (Figure 3.11, upper panel). 
 
An interesting observation in our data is that Cezanne mRNA seems to be unaffected by 
acute laminar flow in PAEC, but is suppressed by flow in PJVECs (Figure 3.11, centre 
panel). 
 
I observed that acute laminar flow induced XIAP by approximately 2-fold in PAEC but 
did not alter the expression of XIAP in PJVEC (Figure 3.11, lower panel). By contrast, 
TNFα induced XIAP in both PAEC and PJVEC (Figure 3.11, lower panel). 
 
Furthermore, we could not observe any reproducible changes in the expression of Keap-
1, Nrf2 or A20 in response to acute laminar flow in either PAEC or PJVEC (Figure 3.12). 
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Figure 3.11 Induction of cytoprotective genes in porcine EC. PAEC and PJVEC were cultured on glass 
slides for 48 hours before they were mounted onto a laminar flow chamber and exposed to flow for 4 hours, 
kept in static conditions or stimulated with TNFα (10 ng/ml) for 2 hours. RT-PCR was performed to 
analyze relative amounts of the genes. The transcript levels were normalised to the housekeeping gene 
cyclophilin, and all the samples are normalised to the PAEC control sample 1. The experiments were 
repeated 3 times for the PAECs and once for PJVEC. Because of extensive variation in the PAEC samples 
the variation is shown in the left column. 
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Figure 3.12 Induction of cytoprotective transcripts in porcine EC. PAEC and PJVEC were cultured on 
glass slides for 48 hours before they were mounted onto a laminar flow chamber and exposed to flow for 4 
hours, kept in static conditions or stimulated with TNFα (10 ng/ml) for 2 hours. Quantitative RT-PCR was 
performed to analyze relative amounts of genes. The transcript levels were normalised to the housekeeping 
gene cyclophilin, and all the samples are normalised to the PAEC control sample 1. The experiments were 
repeated 3 times for the PAECs and once for PJVECs. Because of extensive variation in the PAEC samples 
the variation is shown in the left column. 
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Thus my preliminary data suggests that the anti-inflammatory molecules MKP-1 and 
XIAP are upregulated in response to flow in PAEC but not in PJVEC. This may be 
important in explaining the PAEC comparative resistance to pro-inflammatory activation 
in response acute shear stress. 
 
Further studies are now required to determine whether the preliminary data that I 
generated is genuinely representative of the transcriptional response of PAEC and PJVEC 
to acute laminar flow. 
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4. DISCUSSION 
4.1. Induction of pro-inflammatory transcripts 
We showed that acute laminar flow at arterial shear (12 dynes/cm2) significantly 
upregulated the transcription of the pro-inflammatory chemokines MCP-1 and IL-8 as 
well as the adhesion molecule E-selectin in PJVEC but only had modest effects on 
PAEC.  
 
The differences in MCP-1 and IL-8 transcription in response to acute flow strongly 
suggest that venous EC may have an increased tendency to become activated and recruit 
inflammatory cells in response to shear stress compared to aortic EC. It is possible that 
this initial inflammatory response may lay the foundation for intimal hyperplasia and 
subsequent atherosclerosis which in turn leads to graft failure (see section 1.4.4. for 
details).  
 
Other groups have previously shown that VCAM-1 and ICAM-1 transcript levels are 
upregulated by laminar flow (Burns and DePaola, 2005; Morigi et al., 1995a; Morigi et 
al., 1995b; Nagel et al., 1994), however, we did not see this in our experiments. This may 
be explained by the fact that the other groups looked at 6 hour time point of flow 
exposure, while we looked at 2 and 4 hours of flow exposure.  
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4.2. Pro-inflammatory signalling pathways and their regulation 
4.2.1. p38 
In my western blotting experiments we showed that acute flow did not alter the activation 
of the MAPK p38 in PAEC. However, in PJVEC p38 activation might be upregulated. 
This needs to be confirmed, due to the fact that this experiment only was done once. The 
reason for this was because of the shortage of PJVEC protein lysate, which in turn was a 
result of the complications we encountered in culturing the PJVEC. We were planning to 
repeat the experiment for the PAEC, but we did not have time towards the end of the 
project. It is therefore important for members of our group to now repeat this experiment 
before we can draw strong conclusions about the differences in p38 activation in PAEC 
and PJVEC. It is interesting to note however, that  evidence showing that p38 is essential 
in regulating MCP-1 expression in EC (Goebeler et al., 1999) strenghtens our hypothesis 
that p38 is in fact activated to a lesser extent in PAEC than in PJVEC in response to acute 
flow. 
 
4.2.2. JNK 
As seen in the results section 3.4.2, JNK is transiently upregulated in response to acute 
flow in PAEC. However, in PJVEC the JNK activation is prolonged, which leads to 
increased transcription of AP1-dependent genes, such as MCP-1, IL-8 and E-selectin 
(Hoefen and Berk, 2002). This correlates well with our results showing the increased 
transcription of the pro-inflammatory genes in PJVEC exposed to laminar flow. It would 
be interesting to include further time points in our study to further investigate the kinetics 
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of JNK activation. Because the experiments were done only twice we would have to do at 
least one more repeat to draw strong conclusions. 
 
I analysed EC protein lysates for JNK acivation by ELISA as well (data not shown) with 
a kit from BioSource. However, the results were impossible to determine because none of 
the samples gave a signal above the background signal. This might be because the 
antibodies used were not compatible with porcine versions of JNK, although the 
manufacturer of the kit claims they are. Another possible reason is that the Nucbuster 
lysis buffer used for protein extraction is not compatible with the ELISA kit from 
BioSource. 
 
Previous studies have shown that the E-selectin promoter has an ATF2-c-Jun sequence in 
addition to NF-κB binding sites (Wadgaonkar et al., 2004). The increased E-selectin 
transcription in PJVEC correlates with our findings that the JNK and p38 activation is 
extended in PJVEC compared to PAEC. In addition, it is thought that all the MAPKs 
might under some circumstances act as cytoprotective or antiapoptotic signalling 
molecules. For instance, it has recently been shown that p38 is important in cytoskeletal 
remodelling in response to fluid shear stress, which is an important atheroprotective force 
(Azuma et al. 2001).   
 
I have only considered the activation of p38 and JNK MAP kinases in this project. It is 
therefore important to investigate the ERK and BMK1 pathways as well, as there is 
suggested that there are complex crosstalk between the pro-inflammatory and 
DISCUSSION 
 
 
80 
cytoprotective pathways. Because the pro-inflammatory MAPKs (p38 and JNK) and the 
cytoprotective MAPKs (ERK and BMK1) have contradictory roles, the cellular response 
is regulated by relative activation of the pro-inflammatory and cytoprotective MAPKs 
p38 (Hoefen and Berk, 2002) (Figure 4.1).  
 
 
Figure 4.1 MAPK involvement in endothelial activation Continous high laminar shear stress may 
activate ERK1/2 and BMK1 to a higher extent than p38 and JNK which wouldlead to atheroprotection 
(Hoefen and Berk, 2002) 
 
4.2.3. p65 
I initially wanted to investigate p65 activation in porcine EC in response to flow by using 
the western blot technique. While this technique worked well with the PAEC, we had 
complications with the protein lysates obtained from the cultured PJVEC. As mentioned 
in the results section 3.5, the nuclear lysates seemed to be contaminated with cytosolic 
material. This might be due to lysis buffer degeneration. No matter the cause, these 
particular protein lysates were not usable for further experiments. Because of the 
“contaminated” protein lysated from the PJVECs we could not perform densitometry on 
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the westerns or employ the ELISA kit technique. As a result we had to investigate p65 
activation in PJVEC in response to flow by other means. We decided to do this by 
employing immunohistochemistry (IHC) and the confocal laser-scanning microscopy 
(LSM). This technique worked well with both cell types, and using IHC we found 
conclusively that p65 is located in the cytoplasm of quiescent (control) PAEC and 
PJVEC.  
 
Furthermore, the data suggests that laminar flow triggers transient nuclear localisation of 
p65 which occurred with similar kinetics in PAEC and PJVEC. However, further 
experiments are needed to confirm these data. 
 
4.3. Transcription of anti-inflammatory genes 
As mentioned in the results section (3.6.1) I saw considerable variations in the 
transcription of the anti-inflammatory genes. The reason for this is unclear but may be a 
result of differences in confluency, passage number or in the genetics of the primary EC. 
One “marker” commonly used for indicating the capacity of EC in responce to flow is 
transcription of HO-1 (heme-oxygenase-1), ie. HO-1 is expected to be significantly 
upregulated at transcriptional level by flow. In future studies we should therefore use this 
as a control for EC consistency.  
 
My data suggest that MKP-1 and XIAP may be upregulated in response to acute laminar 
flow in PAEC but not in PJVEC. This is an important observation which suggests that 
PAEC may be able to restrict the initial inflammatory response to flow by limiting the 
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phosphorylation of p38 and JNK through induction of MKP-1 and XIAP (Figure 4.2). 
However, these findings are preliminary and needs to be addressed further.  
 
 
Figure 4.2 Model for restriction of inflammation in PAEC.  We suggest this model for restriction of 
inflammation (and further intimal hyperplasia and graft faliure) in PAEC by induction of MKP-1and XIAP 
transcripts in response to laminar flow. 
 
Regarding the other anti-inflammatory/cytoprotective genes studied, the variation is too 
extensive to draw any firm conclusions. Further studies are therefore required. 
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4.4. Future studies and clinical relevance 
It would be interesting to examine whether specific blocking of p38, JNK and/or NF-κB 
leads to inhibition of MCP-1, IL-8 and E-selectin transcription in EC. We were planning 
to investigate this as a part of this project, but as time ran out for me, other members of 
our group will continue with this investigation using novel pharmacological inhibitors of 
p38 and JNK. 
 
From a clinical point of view, my findings may be of relevance in coronary artery bypass 
grafting. In particular, my study raises the possibility that pre-treating vein grafts with 
inhibitors of MAPK and NF-κB before transpositioning them into arterial circulation may 
reduce inflammation and therefore improve their patency.  
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5. CONCLUSIONS 
 
• Arterial shear stress activates cultured porcine jugular vein endothelial cells 
(PJVEC). 
 
• Acute laminar flow induced high levels of IL-8, MCP-1 and E-selectin transcripts 
in PJVEC.  
 
• By contrast, arterial EC were relatively resistant to the pro-inflammatory effects 
of shear stress. 
 
• The induction of pro-inflammatory mRNA is accompanied by induction of 
cytoprotective transcripts (MKP-1 and XIAP) in PAEC, but not in PJVEC. 
 
• The hypersensitivity of venous EC to flow-mediated pro-inflammatory changes 
may rely on the prolonged (>90mins) activation of JNK and p38 MAP kinases. 
 
• The hypersensitivity of venous EC to the pro-inflammatory effects of shear stress 
may partly explain the susceptibility of vein grafts to inflammation and 
accelerated atherosclerosis. 
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